| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Biqiu Tang, Li Yao, Jeffrey R Strawn, Wenjing Zhang, Su Lu. Neurostructural, Neurofunctional, and Clinical Features of Chronic, Untreated Schizophrenia: A Narrative Review. Schizophrenia bulletin. 2024-08-30. PMID:39212651. |
neurostructural, neurofunctional, and clinical features of chronic, untreated schizophrenia: a narrative review. |
2024-08-30 |
2024-09-04 |
Not clear |
| Garrison J B Dyck, Zaid H Maayah, Dean T Eurich, Jason R B Dyc. Understanding the Potential Benefits of Cannabidiol for Patients With Schizophrenia: A Narrative Review. Schizophrenia bulletin open. vol 3. issue 1. 2024-08-15. PMID:39144756. |
understanding the potential benefits of cannabidiol for patients with schizophrenia: a narrative review. |
2024-08-15 |
2024-08-17 |
Not clear |
| Alexandre González-Rodríguez, Mentxu Natividad, Bruma Palacios-Hernández, Rosa Ayesa-Arriola, Jesús Cobo, José A Monrea. An Evaluation of a Women's Clinic: The Healthcare and Learning Project of the Functional Unit for Women with Schizophrenia. Healthcare (Basel, Switzerland). vol 12. issue 15. 2024-08-09. PMID:39120186. |
the main goal of the present paper is to describe a women's clinic for schizophrenia and carry out a narrative review about innovative healthcare and learning strategies in the context of women who suffer from schizophrenia, and to discuss innovative strategies for both healthcare and learning projects to be applied in this context. |
2024-08-09 |
2024-08-12 |
Not clear |
| Jes Sebastian Denis Völker, M D Ph D Ioana Valentina Micluția, Ramona-Cristina Vinaș. Investigating Cannabidiol's Potential as a Supplementary Treatment for Schizophrenia: A Narrative Review. European journal of pharmacology. 2024-07-28. PMID:39068976. |
investigating cannabidiol's potential as a supplementary treatment for schizophrenia: a narrative review. |
2024-07-28 |
2024-08-02 |
Not clear |
| Dawson W Hedges, Morgan Chase, Thomas J Farrer, Shawn D Gal. Psychiatric Disease as a Potential Risk Factor for Dementia: A Narrative Review. Brain sciences. vol 14. issue 7. 2024-07-27. PMID:39061462. |
because of the high and increasing global prevalence of dementia and the high worldwide prevalence of psychiatric disorders, the primary objective of this narrative review was to evaluate published findings that evaluate the association between bipolar disorder, depression, anxiety, post-traumatic stress disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, autism spectrum disorder, schizophrenia and other psychosis syndromes, and personality disorders and personality traits and incident dementia. |
2024-07-27 |
2024-07-29 |
Not clear |
| Izabela Zajkowska, Patrycja Niczyporuk, Agata Urbaniak, Natalia Tomaszek, Stefan Modzelewski, Napoleon Waszkiewic. Investigating the Impacts of Diet, Supplementation, Microbiota, Gut-Brain Axis on Schizophrenia: A Narrative Review. Nutrients. vol 16. issue 14. 2024-07-27. PMID:39064675. |
investigating the impacts of diet, supplementation, microbiota, gut-brain axis on schizophrenia: a narrative review. |
2024-07-27 |
2024-07-29 |
Not clear |
| Sofia Oskolkov. Schizophrenia: a Narrative Review of Etiological and Diagnostic Issues. Consortium psychiatricum. vol 3. issue 3. 2024-07-24. PMID:39044913. |
schizophrenia: a narrative review of etiological and diagnostic issues. |
2024-07-24 |
2024-07-26 |
Not clear |
| Valerio Ricci, Alessandro Sarni, Giovanni Martinotti, Giuseppe Main. Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review. International clinical psychopharmacology. 2024-06-28. PMID:38941160. |
this narrative review assesses the efficacy, effectiveness, and side effects of third-generation antipsychotics (tgas) like aripiprazole, brexpiprazole, and cariprazine, focusing on their use in first-episode schizophrenia. |
2024-06-28 |
2024-07-01 |
Not clear |
| Robert K Heinssen, Sarah E Morris, Joel T Sherril. National Institute of Mental Health Support for Cognitive Treatment Development in Schizophrenia: A Narrative Review. Schizophrenia bulletin. 2024-06-28. PMID:38941445. |
national institute of mental health support for cognitive treatment development in schizophrenia: a narrative review. |
2024-06-28 |
2024-07-01 |
Not clear |
| Christoph U Correll, Celso Arango, Andrea Fagiolini, Giulia Maria Giordano, Stefan Leucht, Gonzalo Salazar de Pabl. Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline. Neuropsychiatric disease and treatment. vol 20. 2024-06-24. PMID:38911102. |
finding the right setting for the right treatment during the acute treatment of individuals with schizophrenia: a narrative review and clinical practice guideline. |
2024-06-24 |
2024-06-26 |
Not clear |
| Christoph U Correll, Celso Arango, Andrea Fagiolini, Giulia Maria Giordano, Stefan Leucht, Gonzalo Salazar de Pabl. Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline. Neuropsychiatric disease and treatment. vol 20. 2024-06-24. PMID:38911102. |
the aim of this narrative review was to provide suggestions and recommendations for effectively managing patients with schizophrenia during acute exacerbations and to enhance awareness and skills related to personalized medicine. |
2024-06-24 |
2024-06-26 |
Not clear |
| Adonis Sfera, Hassan Imran, Dan O Sfera, Jacob J Anton, Zisis Kozlakidis, Sabine Haza. Novel Insights into Psychosis and Antipsychotic Interventions: From Managing Symptoms to Improving Outcomes. International journal of molecular sciences. vol 25. issue 11. 2024-06-19. PMID:38892092. |
the aim of this narrative review is twofold: (1) to summarize what is known about premature cellular/neuronal senescence in schizophrenia or schizophrenia-like disorders, and (2) to discuss novel strategies for improving long-term outcomes in severe mental illness with natural senotherapeutics, membrane lipid replacement, mitochondrial transplantation, microbial phenazines, novel antioxidant phenothiazines, inhibitors of glycogen synthase kinase-3 beta, and aryl hydrocarbon receptor antagonists. |
2024-06-19 |
2024-06-21 |
Not clear |
| Olivia Egan, Daniel Talbot, Prashanth Mayur, Anthony Harri. Continuation or maintenance ECT for schizophrenia: A narrative review of case report data. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 2024-05-28. PMID:38805612. |
continuation or maintenance ect for schizophrenia: a narrative review of case report data. |
2024-05-28 |
2024-06-03 |
Not clear |
| Yue-Wen Gu, Jing-Wen Fan, Hóngyi Zhào, Shu-Wan Zhao, Xiao-Fan Liu, Renqiang Yu, Lei Ren, Xinjiang Wang, Hong Yin, Long-Biao Cu. Imaging Transcriptomics of the Brain for Schizophrenia. Alpha psychiatry. vol 25. issue 1. 2024-05-27. PMID:38799487. |
we give a narrative focused review on the current transcriptome combined with mri studies related to schizophrenia and summarize the research methodology and content of these studies to identify the research commonalities as well as the implications for future research, in an attempt to provide new insights into the mechanism, clinical diagnosis, and treatments of schizophrenia. |
2024-05-27 |
2024-05-31 |
Not clear |
| . Lived experience narrative: My journey with schizophrenia. The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa. vol 30. 2024-05-10. PMID:38726334. |
lived experience narrative: my journey with schizophrenia. |
2024-05-10 |
2024-05-27 |
Not clear |
| Anna McBride, Gemma Arblaste. Schizophrenia and Orthoptic Conditions: A Literature Review. The British and Irish orthoptic journal. vol 20. issue 1. 2024-04-29. PMID:38681187. |
a narrative review of the literature reporting ocular abnormalities in patients with schizophrenia was undertaken to determine the types and prevalence of orthoptic conditions in this patient cohort. |
2024-04-29 |
2024-05-01 |
Not clear |
| Zosia Swistak MSc, Susan Sookoo Ma, Tom Jewell Ph. Integrating Subjective Recovery and Stigma Resistance in Individuals with Schizophrenia: A Narrative Review and Theoretical Integration. Issues in mental health nursing. 2024-04-29. PMID:38684074. |
integrating subjective recovery and stigma resistance in individuals with schizophrenia: a narrative review and theoretical integration. |
2024-04-29 |
2024-05-03 |
human |
| Petru Fabian Lungu, Corina Miruna Lungu, Alin Ciobica, Ioana Miruna Balmus, Raluca Vitalaru, Ioannis Mavroudis, Romeo Dobrin, Mirela Cimpeanu, Irina Luciana Gurz. The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review. Brain sciences. vol 14. issue 4. 2024-04-27. PMID:38672011. |
the purpose of this narrative review was to examine the effect of antipsychotics on several cognitive domains affected by schizophrenia. |
2024-04-27 |
2024-04-29 |
Not clear |
| Melissa F V Kilicoglu, Nancy B Lundin, Kaley Angers, Aubrey M Mo. Narrative-Derived Indices of Metacognition among People with Schizophrenia: Associations with Self-Reported and Performance-Based Social Functioning. Behavioral sciences (Basel, Switzerland). vol 14. issue 4. 2024-04-26. PMID:38667061. |
the primary objective of this study was to employ a validated language coding system (the metacognition assessment scale, abbreviated; mas-a) to assess metacognitive functioning from the spoken life narratives of individuals with schizophrenia ( |
2024-04-26 |
2024-04-28 |
Not clear |
| Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Oliver D Howes, Niko Seppälä, Christoph U Correl. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 84. 2024-04-24. PMID:38657339. |
overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: a narrative review and recommendation for clinical practice. |
2024-04-24 |
2024-04-28 |
Not clear |